[HTML][HTML] IL-34 is a Treg-specific cytokine and mediates transplant tolerance

S Bézie, E Picarda, J Ossart, L Tesson… - The Journal of …, 2015 - Am Soc Clin Investig
S Bézie, E Picarda, J Ossart, L Tesson, C Usal, K Renaudin, I Anegon, C Guillonneau
The Journal of clinical investigation, 2015Am Soc Clin Investig
Cytokines and metabolic pathway–controlling enzymes regulate immune responses and
have potential as powerful tools to mediate immune tolerance. Blockade of the interaction
between CD40 and CD40L induces long-term cardiac allograft survival in rats through a
CD8+ CD45RClo Treg potentiation. Here, we have shown that the cytokine IL-34, the
immunoregulatory properties of which have not been previously studied in transplantation or
T cell biology, is expressed by rodent CD8+ CD45RClo Tregs and human FOXP3+ …
Cytokines and metabolic pathway–controlling enzymes regulate immune responses and have potential as powerful tools to mediate immune tolerance. Blockade of the interaction between CD40 and CD40L induces long-term cardiac allograft survival in rats through a CD8+CD45RClo Treg potentiation. Here, we have shown that the cytokine IL-34, the immunoregulatory properties of which have not been previously studied in transplantation or T cell biology, is expressed by rodent CD8+CD45RClo Tregs and human FOXP3+CD45RCloCD8+ and CD4+ Tregs. IL-34 was involved in the suppressive function of both CD8+ and CD4+ Tregs and markedly inhibited alloreactive immune responses. Additionally, in a rat cardiac allograft model, IL-34 potently induced transplant tolerance that was associated with a total inhibition of alloantibody production. Treatment of rats with IL-34 promoted allograft tolerance that was mediated by induction of CD8+ and CD4+ Tregs. Moreover, these Tregs were capable of serial tolerance induction through modulation of macrophages that migrate early to the graft. Finally, we demonstrated that human macrophages cultured in the presence of IL-34 greatly expanded CD8+ and CD4+ FOXP3+ Tregs, with a superior suppressive potential of antidonor immune responses compared with non–IL-34–expanded Tregs. In conclusion, we reveal that IL-34 serves as a suppressive Treg–specific cytokine and as a tolerogenic cytokine that efficiently inhibits alloreactive immune responses and mediates transplant tolerance.
The Journal of Clinical Investigation